FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

Janus kinase (JAK) inhibitors are associated with an increased risk for lung cancer but not overall cancer among older patients in the United States with rheumatoid arthritis (RA), according to study ...

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

Rheumatoid arthritis (RA) patients face very different risks for cardiovascular disease and events depending on their body ...

The Bureau of Customs (BOC) and the Philippine Drug Enforcement Agency seized P7,634,000 worth of ecstasy, known as party ...

Based on clinical trial data, abatacept was not associated with increased malignancy risks in RA or PsA; observational data indicated a higher risk vs other b/tsDMARDs.

The 340B drug discount program was created with a noble intent – to ensure that underserved, low-income and uninsured ...

Long-term glucocorticoid (GC) use among older adults with late-onset rheumatoid arthritis (LORA) remains prevalent, despite its known adverse effects, according to study results published in ACR Open ...

Adverse events from disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis decline by as much as 25% after the drugs are established on the market, according to data published ...

JPMorgan economists now estimate the tariffs will result in full-year US gross domestic product declining by 0.3 per cent, ...

Researchers at WashU Medicine have harnessed the internal circadian clock of the body to deliver medication for an ...

A real-world study finds cardiovascular and survival benefits from dual therapy in patients with type 2 diabetes.